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Abstract: Tissue glycation from diabetes and aging can result in 
complications such as renal failure, blindness, nerve damage and vascular 
diseases. In this work, we applied multiphoton microscopy for imaging and 
characterizing the extent of tissue glycation. The characteristic features of 
multiphoton autofluorescence (MPAF) and second harmonic generation 
(SHG) images as well as MPAF spectra of glycated bovine skin, cornea and 
aorta were acquired. The analysis of MPAF intensity change accompanying 
the glycation process shows that collagen is more responsive to the 
formation of autofluorescent advanced glycation endproducts (AGEs) than 
elastic fibers. Changes in spectral features were also used to estimate the 
rate of glycation in tissues with intrinsic AF. Our study shows that 
multiphton imaging may be used for the in vitro investigation of the effects 
of tissue glycation and that this approach may be used for monitoring AGE 
formation in the clinical setting. 
© 2010 Optical Society of America 
OCIS codes: (120.3890) Medical optics instrumentation; (170.5810) Scanning microscopy; 
(170.6510) Spectroscopy, tissue diagnostics; (180.4315) Nonlinear microscopy. 
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1. Introduction 
Protein glycation is initiated by spontaneous non-enzymatic reactions between free amino 
groups on long lived proteins and carbonyl groups of reducing sugars to form a chemically 
reversible Schiff base adducts which are further rearranged in becoming the more stable 
Amadori product. Subsequently, a number of reactions result in the formation of poorly 
characterized structures known as AGEs [1] some of which act as crosslinking agents within 
and between protein molecules [2]. The glycation process and formation of crosslinks are 
thought to contribute to many of the complications seen in aging and diabetes mellitus. The 
extent of tissue glycation depends on the degree of hyperglycaemia, half-life of the protein, 
availability of free amino groups for reaction, and permeability of the tissue to free sugar 
molecules. 
Due to their long half-life, the level of AGEs in collagen acts as a long-term integrator of 
overall glycemia that is insensitive to short- or intermediate-term fluctuations in glycemic 
control [3]. Consequently, AGEs accumulate naturally during healthy aging, but at 
significantly accelerated rates in persons with diabetes. Increased glycation and, in particular, 
accumulation within tissue and serum of AGEs have an important role in the pathogenesis of 
diabetic complications [1,2]. To be specific, the AGE-mediated crosslinking of collagen and 
consequent alterations of structural-mechanical changes in the vascular system is one of the 
causes responsible for development and expression of atherosclerosis and its complications 
such as diabetic vascular stiffening [4]. AGEs can be assayed by invasive procedures 
requiring a biopsy specimen. However, such procedures cannot be used for the frequent 
screening and diagnosis of disease progression in diabetic patients. An accurate, convenient, 
and noninvasive screening test would be an attractive alternative to current methodologies. 
Recent studies have shown that noninvasive optical spectroscopy offers one approach for 
the noninvasive detection of tissue glycation by measuring autofluorescent AGEs in tissues 
such as skin and cornea [5–8]. These studies demonstrate the feasibility of using spectral 
detection of autofluorescence in assessing the degree of tissue glycation in diabetic patients. 
The current techniques of detecting the formation of autofluorescent AGE species use one-
photon excited autofluorescence from AGE species such as crossline and pentosidine [5,6,9]. 
However, without additional visualization aid, it is not possible to separate the contribution of 
autofluorescence from other tissue components such as elastic fibers or cells. Moreover, 
spectral measurements cannot distinguish the effect of glycation on different tissue 
components such as collagen and elastic fibers. Therefore, in the present study, we propose to 
use multiphoton microscopy to demonstrate the feasibility of using multiphoton imaging for 
visualizing and evaluation of glycated tissues and to investigate the effect of glycation on 
collagen and elastic fibers, two of the most important connective tissues in mammals. With 
the known advantages of multiphoton microscopy such as deeper tissue penetration, higher 
special resolution, reduced photodamage, and resolution of second harmonic generating 
collagen fibers, diagnosis of tissue glycation may be improved. 
In this study, we performed multiphoton spectral imaging on bovine cornea, skin, and 
aorta tissues treated with ribose solution to induce glycation. Specifically, multiphoton 
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gathered for image analysis. 
1.1. Materials and method 
Glycated tissue samples preparation 
Three different tissue types of bovine origin that are rich in connective fibers were used in this 
study: cornea, skin, and aorta. All samples were obtained from local markets and processed in 
order to expose the connective tissues intended for our glycation study. Freshly obtained 
corneas were excised from intact eyeballs into button shape 7 mm in diameter. Bovine skin 
was scraped with blades to remove fur and epidermis to expose collagen-rich dermal layer. To 
obtain images of both inner and outer walls of the aorta, thin cross-sectional slices 3-4 mm in 
size were cut from fresh vessels using scalpels. Prior to incubation all samples were cut into 
small sections of equal sizes (approximately 2 × 4 × 15 mm
3), thoroughly washed in 
phosphate buffered saline (PBS) solution, soaked in 1% povidone-iodine solution for about 10 
seconds and washed in PBS. 
Tissue glycation was induced by incubating the tissue in 0.5M ribose solution to mimic 
physiological hyperglycemia. The composition of solutions was obtained from a previous 
work and slightly altered for our needs [10]. One section of each tissue was incubated in 10 
ml of control solution and 3 samples were incubated in the glycation solution composed of 
0.05 M PBS (Sigma-Aldrich, St. Louis, MO), 1% penicillin-streptomycin and 5% dextran 
T500 (Pharmacosmos, Holbaek, Denmark) containing 0.5 M ribose (Sigma, R9629-100G). 
The solution used for the control group tissues had the same chemical composition as the 
glycation solution with ribose excluded. All tissues were incubated at 37°C and 5% of CO2 
condition for different periods of 2, 4, 6, 8, 10 days. Untreated tissue was considered as Day 0 
specimen both for glycated and control specimens. At the end of the incubation period, the 
samples were rinsed with PBS buffer to remove the excess ribose. Vessel and skin samples 
were dissected into smaller pieces (approximately 1 × 2 × 4 mm
3) while the button-shape of 
cornea samples was retained. All samples were sealed within a microscope slide and No. 1.5 
coverglass for imaging purposes. 
Multi-photon microscopy 
The multiphoton microscope used in this study is similar to one described previously [11]. In 
brief, MPAF and SHG images were obtained using laser scanning microscope system (LSM 
510 META, Zeiss, Jena, Germany) coupled to a fs, titanium:sapphire (ti:sa) laser (Tsunami, 
Spectra-Physics, Mountain View, CA). A water immersion objective (Zeiss, C-Apochromat 
40 × /NA 1.2, WD = 0.28 mm) was used for focusing the laser source and collection of the 
emission signal in the epi-illuminated geometry. To explore the multiphoton excitation 
properties of the glycated tissues, excitation wavelengths in the range 720 – 800 nm in steps 
of 20 nm were used. The laser pulse width was estimated to be 100 fs with 80 MHz pulse 
repetition frequency. The average power of laser beam at the sample surface was 30 mW for 
the cornea specimens and 25 mW for skin and vessel tissues. These power limits were 
optimized for acquiring high image contrast while avoiding photobleaching. The images were 
acquired at the depths of approximately 50, 10 and 5 μm from the surfaces of cornea, skin and 
vessel samples respectively. All acquired optical images were 230 × 230 μm
2 in area with 
resolution of 512 x 512 pixels and pixel dwell time of 6.4 μs. 
To visualize tissue glycation on a large scale, a specimen translation stage was used to 
translate the specimen after the acquisition of each small area optical image. In this manner, 9 
adjacent images (3 × 3) were acquired and assembled into a larger-area image 690 × 690 μm
2 
in size [12]. For broad band multiphoton imaging, the luminescence signals were acquired 
using the nondescanned detection (NDD) in which the MPAF and SHG signals were reflected  
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Fig. 1. Time course MPAF (green) and SHG (red) images of glycated and non-glycated 
samples of bovine cornea. The images of non-glycated control tissues are also shown for 
comparison. The laser excitation wavelength was 780 nm and the power was 180 mW. Frame 
size is 620 × 620 μm
2. 
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Fig. 2. Time course MPAF (green) and SHG (red) images of glycated and non-glycated 
samples of bovine skin. The images of non-glycated control tissues are also shown for 
comparison. The laser excitation wavelength was 780 nm and the power was 150 mW. Frame 
size is 620 × 620 μm
2. 
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Fig. 3. Time course MPAF (green) and SHG (red) images of glycated and non-glycated 
specimens of outer aorta. The images of non-glycated control tissues are also shown for 
comparison. The laser excitation wavelength was 780 nm and the power was 180 mW. Frame 
size is 690 × 690 μm
2. 
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Fig. 4. Time course MPAF (green), SHG (red) images of glycated and non-glycated specimens 
of inner aorta. The images of non-glycated control tissues are also shown for comparison. The 
laser excitation wavelength was 780 nm and the power was 180 mW. Frame size is 690 × 690 
μm
2. 
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dichroic mirror (FT 440) and two bandpass filters for the detection of broadband MPAF (435-
700 nm) and SHG (380-400 nm). For spectral imaging, the signal was detected in the 
descanned mode where the reflected excitation beam and specimen luminescence was 
descanned and reflected from a dichroic mirror (HFT KP650) into a grating for 16 channel 
spectral imaging in the 377-720 nm range with a 21.4 nm detection bandwidth. All imaging 
experiments were conducted at the ambient temperature of 19° C. 
1.2. Data collection and analysis 
Prior to analysis and presentation of the large area images (3 × 3 tiles), the images were 
processed with a lateral image heterogeneity correction algorithm. This approach (applied to 
Figs. 1-4) allowed correcting for differences in excitation and collection efficiency within 
each small area image [12]. For quantitative analysis of the spectral data, we selected 5 
regions of interests (ROIs) to compute the average MPAF and SHG intensities. To test 
differences in the glycation rate between collagen and elastic fibers, 5 ROIs (each 70 μm in 
diameter) within the tissue specimens containing either collagen or elastic fibers were selected 
for analysis. The discrimination between the two fiber types was made based on the 
appearance of SHG signal, which was present in collagen but not elastic fibers. At every time 
point, quantitative image analysis was performed. 
2. Results and discussion 
2.1 MPAF and SHG images 
Time course changes in MPAF and SHG of glycated bovine cornea and skin are shown in Fig. 
1 and Fig. 2 respectively. The images of non-glycated (control) tissues are also shown. 
Qualitatively, it is clear that glycation resulted in drastic increase of MPAF intensity and 
moderate decrease in SHG. 
In addition, the images we acquired of outer and inner aorta are shown in Fig. 3 and Fig. 4 
respectively. Since the outer aorta consists of both collagen and elastic fibers while the inner 
aorta is composed primarily of elastic fibers, imaging the two locations within the aorta would 
enable us to determine the effects of glycation on different types of connective tissues. As Fig. 
3 and Fig. 4 show, both collagen and elastic fibers are susceptible to glycation as 
autofluorescence increased for both outer and inner aorta. 
2.2 Quantification of tissue glycation using MPAF and SHG intensities 
From the time-course images of cornea, skin and aorta specimens, the average intensities of 
MPAF and SHG as a function of time were computed. Shown in Fig. 5A, B, C, and D are the 
results for cornea, skin, outer aorta, and inner aorta respectively. Each data point represents 
the average of 15 ROIs from the specimens. The images used for intensity analysis were 
obtained using excitation wavelength of 780 nm. 
As can be clearly seen from Fig. 5, all four specimens showed similar trends for MPAF 
intensity. During the first 2 days the intensity of collagen-rich tissue shows moderate increase. 
However, starting from Day 2, MPAF dramatically increased in a linear fashion. During the 
10-day glycation period, MPAF increased by factors of: 54.5 ± 4.0 in cornea, 17.5 ± 2.3 in 
skin dermal collagen, 1.42 ± 0.3 in elastin of inner aorta, 2.26 ± 0.4 in elastin from outer 
aorta, and 24.9 ± 8.4 in collagen from outer aorta. In contrast, the AF intensity of control 
group remained the same within experimental error for all treatment times. The intensity of 
the SHG signal decreased in glycated cornea and skin. In contrast, no statistically significant 
change of SHG was observed in the control samples. This observation is consistent with 
previous reports and indicates glycation-induced disorder in the collagen structure [13]. In 
comparison, the SHG intensity change of aorta does not show a general tendency but   
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Fig. 5. The dependence of MPAF (left panels) and SHG (right panels) signal intensity of 
cornea (A), skin (B), outer aorta (C),and inner aorta (D) on the incubation time in 0.5 M ribose 
(glycated) or PBS (control). Each data point is an average of 15-16 ROIs. 
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Fig. 6. Relative change of elastin and collagen MPAF intensity from aorta. 30 ROIs of elastic 
fibers where selected from both outer and inner part of aorta. For collagen, 15 ROIs from outer 
aorta were analyzed. The excitation wavelength used for image acquisition was 780 nm and the 
laser power was 150 mW. 
fluctuates with time (Fig. 5, C2). Despite the fact that the presence of SHG can serve as a 
footprint of collagen containing tissue, it is the MPAF rather than SHG signal that is a more 
sensitive metric for the quantitative determination of the extent of tissue glycation. 
In an attempt to compare the relative glycation rates of collagen and elastic fibers, the 
temporal dependence of MPAF intensity was obtained by analyzing signal change at specific 
sites of outer aorta. Figure 6 represents the relative change of MPAF intensity at elastin- and 
collagen-rich sites of aorta. The elastin MPAF increased by a factor of 2.26 ± 0.4 on Day 8 
whereas for collagen the MPAF increased 24.9 ± 8.4 times (Day 10). 
Our results show that collagen is more responsive to the formation of autofluorescent AGEs 
than elastic fibers and indicate that its relatively low intrinsic autofluorescence enables 
collagen to be used for a reliable and accurate determination of tissue glycation. 
2.3 Spectral analysis 
In addition to broadband MPAF analysis, we also employed the lambda mode of the Zeiss 
510 system to measure the MPAF spectral data of all tissues under study at different 
excitation wavelengths of 720, 740, 760, 780 and 800 nm. The images were obtained for 
samples of bovine cornea, skin and aorta treated for 10 days in PBS and ribose solution. The 
spectra of cornea, skin, outer aorta, and inner aorta treated for 10 days are respectively shown 
in Fig. 7(A), (B), (C), and (D) along with the control data. The shape of spectra obtained from 
skin are similar to the ones obtained previously using one-photon excitation of 370-400 nm 
[14]. For all glycated tissues, the position of maxima of spectra is around 495 nm under the 
excitation wavelengths used. However, in the case of outer aorta, the spectra of glycated and 
control specimens are distinctively different. For outer aorta, we observed another feature of 
spectral change and it is the shift of the spectral maximum from about 473 to approximately 
495 nm. This effect is most pronounced for the spectra of control samples and Day 10 
glycated specimens obtained under the excitation of 720 nm and is most likely due to the shift 
of MPAF maxima for elastin in tissue. Specifically, the MPAF maxima are around 473 nm 
under 720 nm excitation and are distinguishable from the spectra of glycated samples with 
maxima at 495 nm. To evaluate the effectiveness of using spectral shift as a measure of 
glycation, we have normalized time course spectra of both glycated and non-glycated tissues 
obtained using 720 nm excitation (Fig. 8). 
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solution. The difference between the Day 10 and Day 0 is presented with dashed line. 
Obviously, the shift and perturbations of the shape of spectra are negligible for the control 
tissues (Fig. 8(A) and Fig. 8(C)). However, the spectra of glycated aorta are red shifted under 
720 nm excitation. This effect is more pronounced for outer aorta (Fig. 8(D)). 
The comparison of spectrum obtained from elastin rich inner part of aorta with the ones 
obtained for collagen-rich sites of outer aorta brings additional information about the origin of 
the observed shift (Fig. 9). 
 
Fig. 7. MPAF spectra of glycated (solid lines) and non-glycated (dashed lines) cornea (A), skin 
(B), outer (C) and inner (D) aorta obtained using the excitations wavelengths of 720, 740, 760, 
780, and 800 nm. 
Clearly, the maxima of both glycated elastin and collagen spectra are around 495 nm, 
whereas the spectral maximum of non-glycated elastin is 473 nm. The fact that the shift is 
evident for elastin explains why similar shift was not found for cornea and skin, where elastin 
is absent or less abundant. This also explains why the spectral shift is more pronounced in 
outer part of the vessel where both elastin and collagen are present. Despite these observations 
it should be noted that the spectral change is not as sensitive as the change in MPAF intensity 
in detecting tissue glycation. Therefore, MPAF intensity change of collagen, rather than 
spectral shift measurements, should be used as the detection mechanism of tissue glycation. 
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Fig. 8. Changes of normalized MPAF spectra of inner (upper panels) and outer (lower panels) 
aorta during the treatment with PBS (control: left panels) and 0.5 M ribose (glycated: right 
panels). The spectra were obtained using λexc = 720 nm. The difference of spectra at Day 10 
and Day 0 is also shown (dashed lines). The arrows in (D) indicate the time course of 
glycation. 
 
Fig. 9. Normalized MPAF spectra of both glycated and non-glycated inner and outer aorta and 
glycated cornea. Spectra were obtained using excitation wavelengths of 720 nm. 
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Multiphoton microscopy has a number of distinct advantages over the conventional methods 
for the non-invasive optical detection of AGEs. The analysis of two-photon AF intensity 
change accompanying the glycation process shows that collagen is more responsive to the 
formation of autofluorescent AGE products than elastic fibers. Changes in spectral features 
can also be used to monitor the rate of glycation in tissues with intrinsic AF. Our study shows 
that multiphoton imaging is capable of providing qualitative and quantitative information of 
the extent of tissue glycation. Provided the correlation between the and conventional 
parameters for degree of glycation (such as HbA1C) and developed non-invasive imaging 
analysis, this approach has potential for monitoring AGE formation in the clinical setting and 
can be applied in both in vivo and in vitro studies aiming at understanding the effect of 
glycation on physiological disorders. 
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